Develops and sells telomerase inhibitor treatments for blood cancers.
| Title |
|---|
| Director, Commercial Omnichannel Orchestration and AI Full Time, Contract, Internship, Temporary, Part Time, Seasonal, Volunteer · $215K-$235K · 9+ YOE Parsippany, New Jersey, United States · Onsite |
| Director, Commercial Data, Systems, and Business Intelligence Full Time · $215K-$235K · 9+ YOE Parsippany, New Jersey, United States · Onsite |
| Director, Sales Operations and Field Effectiveness Full Time · $215K-$235K · 9+ YOE Parsippany, New Jersey, United States · Onsite |
| Associate Director, Financial Planning and Analysis Full Time · $160K-$175K · 7+ YOE Parsippany, New Jersey, United States · Onsite |
| Oncology Key Account Manager - Atlanta Full Time · $195K-$205K · 7+ YOE Atlanta, Georgia, United States · Remote |
| Senior Director, Medical Value Access Liaison - West Full Time · $280K-$295K · 12+ YOE United States · Remote |
| Oncology Key Account Manager - Miami Full Time · $195K-$205K · 7+ YOE Miami or Fort Lauderdale or Naples or Palm Beach or Fort Myers · Remote |
| Oncology Key Account Manager - Hartford Full Time · $195K-$205K · 7+ YOE United States · Remote |
| Oncology Key Account Manager - Seattle Full Time · $195K-$205K · 7+ YOE Washington or Idaho or Montana · Remote |
| Oncology Key Account Manager - Portland Full Time · $195K-$205K · 7+ YOE Oregon, United States · Remote |
| Vice President, Information Technology Full Time · $290K-$325K · 15+ YOE United States · Hybrid |
| Regional Business Director - Great Lakes Full Time · $235K-$270K · 10+ YOE Foster City or Parsippany · Remote |
| Assoc. Dir/Director, Peer-to-Peer Marketing Full Time · $170K-$245K · 7+ YOE Foster City or Parsippany · Remote |
| Oncology Key Account Manager - Indianapolis Full Time · $195K-$205K · 7+ YOE Indianapolis or Indiana · Remote |
| Oncology Key Account Manager - Los Angeles Full Time · $195K-$205K · 7+ YOE United States · Remote |
| Vice President, Clinical Development Full Time · $385K-$425K · 15+ YOE United States · Remote |
| Activities | drug discoveryclinical developmentoncology therapeuticspharmaceutical manufacturinghematology research |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Geron |
| Employees | 230 |
| Type | Public |
| Tagline | Develops and sells telomerase inhibitor treatments for blood cancers. |
| Founded | 1,990 |
| Website | geron.com |
| Stock Exchange | Nasdaq |
| Stock Symbol | GERN |